| Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ... Cell 184 (1), 64-75. e11, 2021 | 1077 | 2021 |
| Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ... The Lancet Infectious Diseases 22 (1), 35-42, 2022 | 814 | 2022 |
| Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13), 2021 | 426 | 2021 |
| Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ... The Lancet Public Health 6 (5), e335-e345, 2021 | 340 | 2021 |
| Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant P Elliott, D Haw, H Wang, O Eales, CE Walters, KEC Ainslie, C Atchison, ... Science 374 (6574), eabl9551, 2021 | 117 | 2021 |
| Clostridioides difficile biofilms: A mechanism of persistence in the gut? LR Frost, JKJ Cheng, M Unnikrishnan PLoS Pathogens 17 (3), e1009348, 2021 | 45 | 2021 |
| Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 infection early in the pandemic and the role of unidentified cases in transmission LB Snell, CL Fisher, U Taj, O Stirrup, B Merrick, A Alcolea-Medina, ... Clinical Microbiology and Infection 28 (1), 93-100, 2022 | 25 | 2022 |
| Dissecting individual interactions between pathogenic and commensal bacteria within a multispecies gut microbial community J Hassall, JKJ Cheng, M Unnikrishnan Msphere 6 (2), 10.1128/msphere. 00013-21, 2021 | 12 | 2021 |
| Refining the Galleria mellonella Model by Using Stress Marker Genes to Assess Clostridioides difficile Infection and Recuperation during Phage Therapy JY Nale, M Chutia, JKJ Cheng, MRJ Clokie Microorganisms 8 (9), 1306, 2020 | 11 | 2020 |
| Diversity, Dynamics and Therapeutic Application of Clostridioides difficile Bacteriophages JY Nale, AM Thanki, SJ Rashid, J Shan, GK Vinner, ASA Dowah, ... Viruses 14 (12), 2772, 2022 | 9 | 2022 |
| Clostridioides difficile infection: traversing host–pathogen interactions in the gut JKJ Cheng, M Unnikrishnan Microbiology 169 (2), 001306, 2023 | 6 | 2023 |
| Novel Escherichia coli-Infecting Bacteriophages Isolated from Uganda That Target Human Clinical Isolates JY Nale, B Chan, NE Nnadi, JKJ Cheng, S Matts, N Nezam-Abadi, ... PHAGE 4 (3), 141-149, 2023 | 1 | 2023 |
| Regulatory Role of Anti-Sigma Factor RsbW in Clostridioides difficile Stress Response, Persistence, and Infection JKJ Cheng, T Đapa, IYL Chan, TO MacCreath, R Slater, M Unnikrishnan Journal of Bacteriology 205 (5), e00466-22, 2023 | 1 | 2023 |
| Investigating the molecular mechanisms in Clostridioides difficile colonisation J Cheng University of Warwick, 2022 | | 2022 |
